Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Net Income towards Common Stockholders (2019 - 2025)

Korro Bio (KRRO) has disclosed Net Income towards Common Stockholders for 6 consecutive years, with -$18.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income towards Common Stockholders rose 13.99% year-over-year to -$18.1 million, compared with a TTM value of -$88.4 million through Sep 2025, down 555.23%, and an annual FY2024 reading of -$83.6 million, down 309459.26% over the prior year.
  • Net Income towards Common Stockholders was -$18.1 million for Q3 2025 at Korro Bio, up from -$25.8 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $48.9 million in Q4 2023 and bottomed at -$25.8 million in Q2 2025.
  • Average Net Income towards Common Stockholders over 5 years is -$15.4 million, with a median of -$20.4 million recorded in 2021.
  • The sharpest move saw Net Income towards Common Stockholders tumbled 370.98% in 2021, then surged 690.3% in 2023.
  • Year by year, Net Income towards Common Stockholders stood at -$21.5 million in 2021, then skyrocketed by 128.77% to $6.2 million in 2022, then soared by 690.3% to $48.9 million in 2023, then crashed by 143.36% to -$21.2 million in 2024, then grew by 14.8% to -$18.1 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for KRRO at -$18.1 million in Q3 2025, -$25.8 million in Q2 2025, and -$23.4 million in Q1 2025.